Comparison of outcomes by modality for critically ill patients requiring renal replacement therapy: A single-centre cohort study adjusting for time-varying illness severity and modality exposure

Anaesthesia and Intensive Care

Volumn 40, Issue 2, 2012, Pages 260-268

  Khanal, N ^a,b   Marshall, M R ^a,c,d   Ma, T M ^a,e   Pridmore, P J ^a,f   Williams, A B ^a   Rankin, A P N ^a  

^a Manukau SuperClinic   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^f FREMANTLE HOSPITAL   (Australia)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Critical care nephrology; Prolonged intermittent renal replacement therapy; Sustained low efficiency dialysis

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84858973814     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000208     Document Type: Conference Paper

References (61)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294:813-818. (Pubitemid 41175724)
2. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17:1143-1150.
3. Ympa YP, Sakr Y, Reinhart K, Vincent J-L. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005; 118:827-832. (Pubitemid 41097456)
4. Basso F, Ricci Z, Cruz D, Ronco C. International survey on the management of acute kidney injury in critically ill patients: year 2007. Blood Purif 2010; 30:214-220.
5. Overberger P, Pesacreta M, Palevsky PM. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007; 2:623-630.
6. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;CD003773.
7. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40:875-885. (Pubitemid 35265466)
8. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008; 299:793-805. (Pubitemid 351281573)
9. Marshall MR, Creamer JM, Foster M, Ma TM, Mann SL, Fiaccadori E et al. Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in three intensive care units from different countries. Nephrol Dial Transplant 2011; 26:2169-2175.
10. Lonnemann G, Floege J, Kliem V, Brunkhorst R, Koch KM. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant 2000; 15:1189-1193. (Pubitemid 30487796)
11. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60:777-785. (Pubitemid 32678922)
12. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000; 36:294-300. (Pubitemid 30485837)
13. Naka T, Baldwin I, Bellomo R, Fealy N, Wan L. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs 2004; 27:380-387. (Pubitemid 38812185)
14. Berbece AN, Richardson RMA. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int 2006; 70:963-968. (Pubitemid 44285975)
15. Fiaccadori E, Maggiore U, Parenti E, Giacosa R, Picetti E, Rotelli C et al. Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure. Nephrol Dial Transplant 2007; 22:529-537. (Pubitemid 46189898)
16. Bellomo R, Baldwin I, Fealy N. Prolonged intermittent renal replacement therapy in the intensive care unit. Crit Care Resusc 2002; 4:281-290.
17. Holt BG, White JJ, Kuthiala A, Fall P, Szerlip HM. Sustained low-efficiency daily dialysis with hemofiltration for acute kidney injury in the presence of sepsis. Clin Nephrol 2008; 69:40-46.
18. Wu VC, Wang C-H, Wang W-J, Lin Y-F, Hu F-C, Chen Y-W et al. Sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for postsurgical acute renal failure. Am J Surg 2010; 199:466-476.
19. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560. (Pubitemid 30660034)
20. Vonesh EF, Schaubel DE, Hao W, Collins AJ. Statistical methods for comparing mortality among ESRD pateints: examples of regional/international variations. Kidney Int 2000; 57 (Suppl 74):S19-27.
21. College of Intensive Care Medicine of Australia and New Zealand. Minimum standards for intensive care units. From http://cicm.org.au/policydocs.php. Accessed April 2010.
22. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-212.
23. Marshall MR, Ma TM, Galler D, Rankin APN, Williams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19:877-884. (Pubitemid 38455659)
24. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006; 34:1297-1310.
25. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710.
26. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008; 168: 656-664.
27. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-570. (Pubitemid 30660035)
28. Hernan MA, Brumback BA, Robins JM. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med 2002; 21:1689-1709. (Pubitemid 34678901)
29. Marshall MR, Hawley CM, Kerr PG, Polkinghorne KR, Marshall RJ, Agar JWM et al. Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis 2011; 58:782-793.
30. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004; 15:615-625. (Pubitemid 40416916)
31. Robins JM. Estimation of the time-dependent accelerated failure time model in the presence of confounding factors. Biometrika 1992; 79:321-334.
32. Bodnar LM, Davidian M, Siega-Riz AM, Tsiatis AA. Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol 2004; 159:926-934. (Pubitemid 38608269)
33. Cole SR, Hernan MA, Margolick JB, Cohen MH, Robins JM. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol 2005; 162:471-478. (Pubitemid 41191433)
34. Cole SR, Hernan MA, Robins JM, Anastos K, Chmiel J, Detels R et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol 2003; 158:687-694. (Pubitemid 37175517)
35. Cook NR, Cole SR, Hennekens CH. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol 2002; 155:1045-1053. (Pubitemid 34587488)
36. Fewell Z, Hernan MA, Wolfe F, Tilling K, Choi H, Sterne J. Controlling for time-dependent confounding using marginal structural models. The Stata Journal 2004; 4:402-420.
37. Comment: demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data.
38. Schafer JL, Kang J. Average causal effects from nonrandomized studies: a practical guide and simulated example. Psychol Methods 2008; 13:279-313.
39. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28:29-37. (Pubitemid 34118972)
40. Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H et al. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2009; 24:2179-2186.
41. Gashti CN, Salcedo S, Robinson V, Rodby RA. Accelerated venovenous hemofiltration: early technical and clinical experience. Am J Kidney Dis 2008; 51:804-810. (Pubitemid 351626249)
42. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 2004; 27:371-379. (Pubitemid 38812184)
43. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43:342-349. (Pubitemid 38146333)
44. Abe M, Okada K, Suzuki M, Nagura C, Ishihara Y, Fujii Y et al. Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury. Artif Organs 2010; 34:331-338.
45. Lins R, Elseviers M, Van der Niepen P. Outcome of different treatment modalities in ARF: randomized population. J Am Soc Nephrol 2004; 14:195A.
46. Malbrain M, Elseviers M, Van Der Niepen P, Damas P, Hoste E, Devriendt J et al. Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities. Critical Care 2004; 8 (Suppl 1):P153.
47. Lins RL, Elseviers MM, Van der Niepen P, Hoste E, Malbrain ML, Damas P et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 2009; 24:512-518.
48. Gedmintas A, Crilly J, Richards B, Comadira GP, Creamer J, Lind J et al. Haemodynamic stability is maintained during extended daily diafiltration in critically ill septic patients. Crit Care Resusc 2010; 12:203-208.
49. Baldwin I, Bellomo R, Naka T, Koch B, Fealy N. A pilot randomized controlled comparison of extended daily dialysis with filtration and continuous veno-venous hemofiltration: fluid removal and hemodynamics. Int J Artif Organs 2007; 30:1083-1089. (Pubitemid 351188061)
50. Fieghen HE, Friedrich JO, Burns KE, Nisenbaum R, Adhikari NK, Hladunewich MA et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol 2010; 11:32.
51. Kron J, Kron S, Wenkel R, Schuhmacher HU, Thieme U, Leimbach T et al. Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure. Nephrol Dial Transplant 2011; [Epub ahead of print].
52. Marcelino P, Marum S, Fernandes AP, Ribeiro JP. [Hybrid or continuous renal replacement techniques for unstable haemodynamic patients in the intensive care unit]. Acta Med Port 2006; 19:275-280.
53. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Goldsmith D et al. Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. Blood Purif 2008; 26:407-416.
54. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627-1638.
55. Palevsky PM, O'Connor T, Zhang JH, Star RA, Smith MW. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials 2005; 2:423-435. (Pubitemid 41586027)
56. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7-20. (Pubitemid 351931092)
57. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001; 29:880-886. (Pubitemid 32299732)
58. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005; 9:R700-709.
59. Petitti DB, Freedman DA. Invited commentary: how far can epidemiologists get with statistical adjustment? Am J Epidemiol 2005; 162:415-418; discussion 419-420.
60. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 2005; 162: 404-414. (Pubitemid 41191425)
61. Bandyopadhyay S, Jakobson D, Chhabra KD, Baker A. Improvement of cerebral blood flow patterns in hepatorenal syndrome using sustained low-efficiency dialysis. Br J Anaesth 2010; 105:547-548.